NCT06197321

Brief Summary

The goal of this observational study is to study a new method to compute ventricular-arterial coupling (VAC) in adult intensive care patients after cardiac surgery. VAC is a metric that describes the interaction between the heart and the arterial system. The new method of measuring VAC uses carotid ultrasound measurements. The main questions this study aims to answer are:

  • Can VAC measured using carotid ultrasound predict the hemodynamic response to drugs?
  • What is the concordance of VAC measurements obtained via carotid ultrasound with VAC measurements obtained via the standard, single-beat method? Measurements will be performed in the operating room and at the ICU.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 5, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 9, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

January 15, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 18, 2025

Status Verified

September 1, 2024

Enrollment Period

11 months

First QC Date

December 5, 2023

Last Update Submit

February 14, 2025

Conditions

Keywords

Ventriculo-arterial couplingCarotid ultrasound

Outcome Measures

Primary Outcomes (1)

  • The prediction of the hemodynamic response to norepinephrine or fluids using carotid ultrasound measurements.

    It will be studied if carotid ultrasound measurements can be used to predict a hemodynamic response to hemodynamic drugs, where the hemodynamic response is defined as a 15% increase in stroke volume.

    Through study completion, an average of 1 year.

Secondary Outcomes (1)

  • The concordance of ventricular-arterial coupling (VAC) measurements obtained using carotid ultrasound measurements with VAC measurements obtained using the single-beat method.

    Through study completion, an average of 1 year.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Adult ICU patients after cardiac surgery.

You may qualify if:

  • Adult patients (≥18 years)
  • Admitted to the ICU after cardiac surgery

You may not qualify if:

  • No informed consent for study participation
  • Within the first 3 hours of ICU admission noradrenaline infusion is not increased or started, and/or a fluid bolus is not given; both on indication of the attending physician
  • Patient with chronic obstructive pulmonary disease (COPD) gold stage 3 or 4
  • Pregnancy
  • Moderate to severe aortic valve disease
  • Atrial fibrillation
  • Carotid artery stenosis \>50%
  • History of cerebrovascular accident or transient ischemic attack
  • History of cerebral trauma
  • Morbid obesity (BMI \>40 kg/m2)
  • Emergency surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Catharina Ziekenhuis

Eindhoven, North Brabant, 5652 EJ, Netherlands

Location

MeSH Terms

Conditions

ShockAortic Valve DiseaseCoronary Artery Disease

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesCoronary DiseaseMyocardial IschemiaArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • R. A. Bouwman, Prof.

    Catharina Ziekenhuis Eindhoven

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 5, 2023

First Posted

January 9, 2024

Study Start

January 15, 2024

Primary Completion

November 30, 2024

Study Completion

December 31, 2024

Last Updated

February 18, 2025

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations